Pre-transplant optimization by Molecular Adsorbent Recirculating System in patients with severely decompensated chronic liver disease. |
| |
Authors: | Gajanan D Wagholikar Kang-Hoe Lee Durgatosh Pandey See-Odd Leong Ranjodh Singh Kai-Chah Tan |
| |
Affiliation: | Asian Center for Liver Diseases and Transplantation, Gleneagles Hospital, Singapore. |
| |
Abstract: | BACKGROUND: The outcome of liver transplantation (LT) is influenced by the recipient's clinical condition. In a retrospective observational study, we evaluated the role of pre-LT Molecular Adsorbent Recirculating System (MARS) treatment in improving the clinical status and thereby the outcome of patients with chronic liver disease and severe hepatic decompensation. METHODS: Between March 2002 and September 2006, 70 patients with end-stage chronic liver disease underwent living-donor LT (LDLT). Of these, 9 (13%) patients with severely decompensated liver function (serum bilirubin> 350 micromol/L [20 mg/dL] and/or hepatic encephalopathy > or = grade 2) received pre-LT MARS treatment. RESULTS: The median MELD score was 33 (range, 26-47). A median of 2 (range, 1-6) sessions (8 hour/session) of MARS dialysis was performed per patient. MARS treatment was associated with reduction in serum bilirubin, creatinine and ammonia levels and no procedure-related complications. CONCLUSION: Pre-LT MARS is well tolerated and results in reduction of jaundice and improvement in renal function and may be useful in the management of patients with severe hepatic decompensation. |
| |
Keywords: | |
|
|